The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases
Among a number of innate receptors, the nucleotide-binding domain leucine-rich repeat containing (NLR) nucleotide oligomerization domain (NOD)-like receptor families are involved in the recognition of cytosolic pathogen- or danger-associated molecules. Activation of these specific sets of receptors...
Saved in:
Published in | International neurourology journal Vol. 16; no. 1; pp. 2 - 12 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Continence Society
01.03.2012
대한배뇨장애요실금학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2093-4777 2093-6931 2093-6931 |
DOI | 10.5213/inj.2012.16.1.2 |
Cover
Abstract | Among a number of innate receptors, the nucleotide-binding domain leucine-rich repeat containing (NLR) nucleotide oligomerization domain (NOD)-like receptor families are involved in the recognition of cytosolic pathogen- or danger-associated molecules. Activation of these specific sets of receptors leads to the assembly of a multiprotein complex, the inflammasome, leading to the activation of caspase-1 and maturation of the cytokines interleukin (IL)-1β, IL-18, and IL-33. Among NLRs, NLR-related protein 3 (NLRP3) is one of the best-characterized receptors that activates the inflammasome. There is no doubt that NLRP3 inflammasome activation is important for host defense and effective pathogen clearance against fungal, bacterial, and viral infection. In addition, mounting evidence indicates that the NLRP3 inflammasome plays a role in a variety of inflammatory diseases, including gout, atherosclerosis, and type II diabetes, as well as under conditions of cellular stress or injury. Here, we review recent advances in our understanding of the role of the NLRP3 inflammasome in host defense and various inflammatory diseases. |
---|---|
AbstractList | Among a number of innate receptors, the nucleotide-binding domain leucine-rich repeat containing (NLR) nucleotide oligomerization domain (NOD)-like receptor families are involved in the recognition of cytosolic pathogen- or danger-associated molecules.
Activation of these specific sets of receptors leads to the assembly of a multiprotein complex, the inflammasome, leading to the activation of caspase-1 and maturation of the cytokines interleukin (IL)-1β, IL-18, and IL-33. Among NLRs, NLR-related protein 3 (NLRP3) is one of the best-characterized receptors that activates the inflammasome. There is no doubt that NLRP3 inflammasome activation is important for host defense and effective pathogen clearance against fungal, bacterial, and viral infection.
In addition, mounting evidence indicates that the NLRP3 inflammasome plays a role in a variety of inflammatory diseases, including gout, atherosclerosis, and type II diabetes, as well as under conditions of cellular stress or injury. Here, we review recent advances in our understanding of the role of the NLRP3 inflammasome in host defense and various inflammatory diseases. KCI Citation Count: 50 Among a number of innate receptors, the nucleotide-binding domain leucine-rich repeat containing (NLR) nucleotide oligomerization domain (NOD)-like receptor families are involved in the recognition of cytosolic pathogen- or danger-associated molecules. Activation of these specific sets of receptors leads to the assembly of a multiprotein complex, the inflammasome, leading to the activation of caspase-1 and maturation of the cytokines interleukin (IL)-1β, IL-18, and IL-33. Among NLRs, NLR-related protein 3 (NLRP3) is one of the best-characterized receptors that activates the inflammasome. There is no doubt that NLRP3 inflammasome activation is important for host defense and effective pathogen clearance against fungal, bacterial, and viral infection. In addition, mounting evidence indicates that the NLRP3 inflammasome plays a role in a variety of inflammatory diseases, including gout, atherosclerosis, and type II diabetes, as well as under conditions of cellular stress or injury. Here, we review recent advances in our understanding of the role of the NLRP3 inflammasome in host defense and various inflammatory diseases.Among a number of innate receptors, the nucleotide-binding domain leucine-rich repeat containing (NLR) nucleotide oligomerization domain (NOD)-like receptor families are involved in the recognition of cytosolic pathogen- or danger-associated molecules. Activation of these specific sets of receptors leads to the assembly of a multiprotein complex, the inflammasome, leading to the activation of caspase-1 and maturation of the cytokines interleukin (IL)-1β, IL-18, and IL-33. Among NLRs, NLR-related protein 3 (NLRP3) is one of the best-characterized receptors that activates the inflammasome. There is no doubt that NLRP3 inflammasome activation is important for host defense and effective pathogen clearance against fungal, bacterial, and viral infection. In addition, mounting evidence indicates that the NLRP3 inflammasome plays a role in a variety of inflammatory diseases, including gout, atherosclerosis, and type II diabetes, as well as under conditions of cellular stress or injury. Here, we review recent advances in our understanding of the role of the NLRP3 inflammasome in host defense and various inflammatory diseases. Among a number of innate receptors, the nucleotide-binding domain leucine-rich repeat containing (NLR) nucleotide oligomerization domain (NOD)-like receptor families are involved in the recognition of cytosolic pathogen- or danger-associated molecules. Activation of these specific sets of receptors leads to the assembly of a multiprotein complex, the inflammasome, leading to the activation of caspase-1 and maturation of the cytokines interleukin (IL)-1β, IL-18, and IL-33. Among NLRs, NLR-related protein 3 (NLRP3) is one of the best-characterized receptors that activates the inflammasome. There is no doubt that NLRP3 inflammasome activation is important for host defense and effective pathogen clearance against fungal, bacterial, and viral infection. In addition, mounting evidence indicates that the NLRP3 inflammasome plays a role in a variety of inflammatory diseases, including gout, atherosclerosis, and type II diabetes, as well as under conditions of cellular stress or injury. Here, we review recent advances in our understanding of the role of the NLRP3 inflammasome in host defense and various inflammatory diseases. |
Author | Yang, Chul-Su Shin, Dong-Min Jo, Eun-Kyeong |
AuthorAffiliation | Department of Microbiology, Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon, Korea |
AuthorAffiliation_xml | – name: Department of Microbiology, Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon, Korea |
Author_xml | – sequence: 1 givenname: Chul-Su surname: Yang fullname: Yang, Chul-Su organization: Department of Microbiology, Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon, Korea – sequence: 2 givenname: Dong-Min surname: Shin fullname: Shin, Dong-Min organization: Department of Microbiology, Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon, Korea – sequence: 3 givenname: Eun-Kyeong surname: Jo fullname: Jo, Eun-Kyeong organization: Department of Microbiology, Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22500248$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001647947$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1ks1r3DAQxUVJaZJtzr0VH5uDHX3buhRC0iYLS1uWPfQmZHmcaGNLqeQt5L-v9iOhKVQXidF7v3kwc4qOfPCA0AeCK0EJu3B-XVFMaEVkRSr6Bp1QrFgpFSNHhzev6_oYnaW0xvlwXmNRv0PHlAqMKW9O0M_VPRTLMEAR-uLbYllGGMwEXfEjhgmcL1gx9_1gxtGkMEKRK7chTcU19OATFMZ3L4IpxKfi2iUwCdJ79LY3Q4Kzwz1Dq69fVle35eL7zfzqclFaIdRUUjCio8AYb4giwoKAvqadwQQD761sObeqAYAWK8OlstJKwEI1TFqhMJuh8z3Wx14_WKeDcbv7LuiHqC-Xq7kmmMiasKyd77VdMGv9GN1o4tPOsCuEeKdNnJwdQMuuaUkHBgTJybhsGa8Na4Vkirem7jPr8571uGlH6Cz4KZrhFfT1j3f3OdNvzVgenVIZ8OkAiOHXBtKkR5csDIPxEDYph87zwgzn4DP08e9eL02ep5gFYi-wMaQUodfWTWZyYdvaDZmltwuj88Lo7cJoIjXRNPsu_vE9o__n-AM7c8GO |
CitedBy_id | crossref_primary_10_1021_acsomega_4c00056 crossref_primary_10_1155_2017_2438247 crossref_primary_10_3346_jkms_2013_28_10_1415 crossref_primary_10_1155_2014_297293 crossref_primary_10_3390_cells10123522 crossref_primary_10_1152_ajpcell_00356_2021 crossref_primary_10_1016_j_joen_2014_01_021 crossref_primary_10_1371_journal_ppat_1003407 crossref_primary_10_1186_s12882_022_02755_1 crossref_primary_10_1038_s41420_023_01438_6 crossref_primary_10_1007_s00011_014_0774_9 crossref_primary_10_1016_j_joen_2017_06_011 crossref_primary_10_1155_2014_403515 crossref_primary_10_1155_2022_8528938 crossref_primary_10_1111_etp_12036 crossref_primary_10_3389_fcimb_2018_00081 crossref_primary_10_1016_j_lfs_2020_117727 crossref_primary_10_1111_imm_13134 crossref_primary_10_1111_prd_12084 crossref_primary_10_1016_j_toxlet_2015_04_012 crossref_primary_10_2147_JIR_S436147 crossref_primary_10_1093_abbs_gmz098 crossref_primary_10_3892_mmr_2013_1429 crossref_primary_10_2147_JIR_S370483 crossref_primary_10_5812_jssc_108996 crossref_primary_10_1177_1470320320926049 crossref_primary_10_1111_micc_12585 crossref_primary_10_1016_j_envint_2024_108631 crossref_primary_10_1155_2016_1258504 crossref_primary_10_2217_fmb_15_37 crossref_primary_10_12677_ACM_2018_86090 crossref_primary_10_1073_pnas_1306556110 crossref_primary_10_3892_ijmm_2018_3710 crossref_primary_10_1016_j_biopha_2021_112219 crossref_primary_10_3892_ijmm_2015_2129 crossref_primary_10_1161_HYPERTENSIONAHA_119_12831 crossref_primary_10_3390_nu16244301 crossref_primary_10_1016_j_cytox_2020_100032 crossref_primary_10_1080_08923973_2020_1746967 crossref_primary_10_3389_fendo_2022_835054 crossref_primary_10_1155_2019_6193186 crossref_primary_10_1007_s10067_018_4149_4 crossref_primary_10_5812_jjm_88231 crossref_primary_10_1016_j_preghy_2018_07_006 crossref_primary_10_1089_jop_2012_0141 crossref_primary_10_1371_journal_pone_0129095 crossref_primary_10_1002_eji_201848016 crossref_primary_10_1016_j_intimp_2024_112336 crossref_primary_10_5213_inj_2012_16_1_1 crossref_primary_10_1002_cai2_29 crossref_primary_10_1016_j_genrep_2021_101093 crossref_primary_10_1042_CS20201419 crossref_primary_10_1177_0961203316644336 crossref_primary_10_1016_j_bbalip_2021_159061 crossref_primary_10_33549_physiolres_934759 crossref_primary_10_1007_s00784_014_1361_8 crossref_primary_10_1016_j_ecoenv_2022_114329 crossref_primary_10_1155_2019_9306283 crossref_primary_10_1016_j_freeradbiomed_2019_10_416 crossref_primary_10_3892_ijmm_2019_4176 crossref_primary_10_3892_mmr_2019_10172 crossref_primary_10_1016_j_jdsr_2018_03_001 crossref_primary_10_1039_D0NA00478B |
Cites_doi | 10.1371/journal.pone.0011765 10.1002/art.1780180208 10.1038/nature04515 10.1086/374751 10.1038/sj.cdd.4402195 10.1371/journal.pone.0029695 10.4049/jimmunol.0903937 10.1038/nature05482 10.1016/j.coi.2009.12.004 10.1164/rccm.200808-1274OC 10.1002/art.23687 10.2337/db09-0659 10.1111/j.1462-5822.2011.01625.x 10.1136/ard.2009.109355 10.1038/ni.1831 10.4049/jimmunol.0902477 10.2337/diabetes.54.10.2932 10.1128/JVI.01687-10 10.1126/science.1184003 10.1074/jbc.M111.244079 10.1099/vir.0.034033-0 10.4049/jimmunol.0802696 10.1038/ni.1859 10.1038/cddis.2011.132 10.1074/jbc.M607594200 10.1097/QAI.0b013e3181dd17d4 10.1186/ar2143 10.2337/db09-0949 10.1111/j.1462-5822.2010.01450.x 10.1038/ng756 10.4049/jimmunol.0901323 10.2741/3812 10.1371/journal.ppat.1002452 10.1371/journal.pone.0010008 10.1126/science.3086977 10.1016/j.immuni.2006.02.004 10.1038/ni.1636 10.1038/ni1346 10.2337/diabetes.52.3.812 10.1111/j.1462-5822.2007.00996.x 10.1038/nature08938 10.1016/j.ejim.2010.03.005 10.1146/annurev.immunol.25.022106.141627 10.4049/jimmunol.175.4.2630 10.5551/jat.7591 10.1002/art.27600 10.1136/ard.2007.073759 10.1016/S0140-6736(04)17401-1 10.1038/nature10759 10.1038/ni1344 10.1371/journal.pone.0012320 10.1210/en.2009-0543 10.1038/nature07965 10.1038/nature04516 10.1056/NEJM199901143400207 10.1517/14712590903136688 10.1038/nature09663 10.4049/jimmunol.0903019 10.1038/ni.1702 10.1086/341357 10.1073/pnas.84.23.8628 10.1002/eji.201141548 10.1371/journal.pone.0007446 10.1074/jbc.M110.210575 10.4049/jimmunol.0903536 10.1371/journal.ppat.1000480 10.1038/nm.2028 10.1074/jbc.M401178200 10.1016/j.jacl.2010.03.003 10.1016/S1074-7613(04)00046-9 10.1146/annurev.immunol.021908.132612 10.1111/j.1600-065X.2008.00731.x 10.1371/journal.ppat.1000510 10.1371/journal.ppat.1000895 10.1098/rstb.2011.0106 10.1016/j.chom.2009.05.002 10.1084/jem.20100257 10.1038/ni.1824 10.1016/j.it.2011.05.004 10.1056/NEJM200306193482523 10.1038/nrrheum.2010.222 10.1073/pnas.0810087106 10.4049/jimmunol.0900444 10.1038/nri2925 10.4049/jimmunol.1002854 10.1002/art.23119 10.1038/ni.1980 10.1038/ni.1631 10.1038/ni.1935 10.1002/art.24185 10.1136/ard.58.2008.i96 10.1136/ard.2009.108936 10.1016/j.chom.2008.03.003 |
ContentType | Journal Article |
Copyright | Copyright © 2012 Korean Continence Society 2012 |
Copyright_xml | – notice: Copyright © 2012 Korean Continence Society 2012 |
DBID | AAYXX CITATION NPM 7X8 5PM DOA ACYCR |
DOI | 10.5213/inj.2012.16.1.2 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ : directory of open access journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2093-6931 |
EndPage | 12 |
ExternalDocumentID | oai_kci_go_kr_ARTI_1016713 oai_doaj_org_article_6d8b1deae5134846b347a3b56394ba7f PMC3321399 22500248 10_5213_inj_2012_16_1_2 |
Genre | Journal Article |
GroupedDBID | --- 5-W 53G 8JR 8XY 9ZL AAKDD AAYXX ABDBF ACUHS ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK E3Z EBD EF. F5P GROUPED_DOAJ HYE OK1 RPM NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c559t-2ea5d2e33481915ce5ef72da010e4fc6b44c98eeeb09a469c6c6e059836c5903 |
IEDL.DBID | DOA |
ISSN | 2093-4777 2093-6931 |
IngestDate | Sun Mar 09 07:53:25 EDT 2025 Wed Aug 27 01:21:09 EDT 2025 Thu Aug 21 18:23:41 EDT 2025 Fri Jul 11 01:49:15 EDT 2025 Thu Jan 02 22:11:09 EST 2025 Thu Apr 24 23:04:35 EDT 2025 Tue Jul 01 00:28:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Inflammasomes Defense mechanisms Inflammation |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c559t-2ea5d2e33481915ce5ef72da010e4fc6b44c98eeeb09a469c6c6e059836c5903 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-001728.2012.16.1.004 |
OpenAccessLink | https://doaj.org/article/6d8b1deae5134846b347a3b56394ba7f |
PMID | 22500248 |
PQID | 1000403071 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1016713 doaj_primary_oai_doaj_org_article_6d8b1deae5134846b347a3b56394ba7f pubmedcentral_primary_oai_pubmedcentral_nih_gov_3321399 proquest_miscellaneous_1000403071 pubmed_primary_22500248 crossref_citationtrail_10_5213_inj_2012_16_1_2 crossref_primary_10_5213_inj_2012_16_1_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-03-01 |
PublicationDateYYYYMMDD | 2012-03-01 |
PublicationDate_xml | – month: 03 year: 2012 text: 2012-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | International neurourology journal |
PublicationTitleAlternate | Int Neurourol J |
PublicationYear | 2012 |
Publisher | Korean Continence Society 대한배뇨장애요실금학회 |
Publisher_xml | – name: Korean Continence Society – name: 대한배뇨장애요실금학회 |
References | Kankkunen (10.5213/inj.2012.16.1.2_ref28) 2010; 184 Bürckstümmer (10.5213/inj.2012.16.1.2_ref50) 2009; 10 Spranger (10.5213/inj.2012.16.1.2_ref71) 2003; 52 Pontillo (10.5213/inj.2012.16.1.2_ref53) 2010; 54 Rajamäki (10.5213/inj.2012.16.1.2_ref69) 2010; 5 Joly (10.5213/inj.2012.16.1.2_ref25) 2009; 183 Mizuno (10.5213/inj.2012.16.1.2_ref64) 2011; 18 Lamkanfi (10.5213/inj.2012.16.1.2_ref7) 2009; 5 Mishra (10.5213/inj.2012.16.1.2_ref40) 2010; 12 Schroder (10.5213/inj.2012.16.1.2_ref13) 2010; 327 Toma (10.5213/inj.2012.16.1.2_ref31) 2010; 184 Master (10.5213/inj.2012.16.1.2_ref39) 2008; 3 De Nardo (10.5213/inj.2012.16.1.2_ref12) 2011; 32 Chen (10.5213/inj.2012.16.1.2_ref82) 2010; 59 Dinarello (10.5213/inj.2012.16.1.2_ref22) 2003; 187 Espinola-Klein (10.5213/inj.2012.16.1.2_ref66) 2011; 16 Fernandes-Alnemri (10.5213/inj.2012.16.1.2_ref37) 2010; 11 Thorand (10.5213/inj.2012.16.1.2_ref72) 2005; 54 Ghiringhelli (10.5213/inj.2012.16.1.2_ref16) 2009; 15 Martinon (10.5213/inj.2012.16.1.2_ref10) 2006; 440 Lee (10.5213/inj.2012.16.1.2_ref44) 2011 Ross (10.5213/inj.2012.16.1.2_ref63) 1999; 340 Zhou (10.5213/inj.2012.16.1.2_ref17) 2011; 469 Dorhoi (10.5213/inj.2012.16.1.2_ref42) 2012; 42 Kumar (10.5213/inj.2012.16.1.2_ref26) 2009; 183 Miao (10.5213/inj.2012.16.1.2_ref32) 2006; 7 Masters (10.5213/inj.2012.16.1.2_ref79) 2010; 11 Halle (10.5213/inj.2012.16.1.2_ref19) 2008; 9 Hoffman (10.5213/inj.2012.16.1.2_ref88) 2008; 58 McElvania Tekippe (10.5213/inj.2012.16.1.2_ref41) 2010; 5 Nakahira (10.5213/inj.2012.16.1.2_ref18) 2011; 12 Dinarello (10.5213/inj.2012.16.1.2_ref23) 2009; 27 Franchi (10.5213/inj.2012.16.1.2_ref14) 2006; 7 Bresnihan (10.5213/inj.2012.16.1.2_ref85) 1999; 58 So (10.5213/inj.2012.16.1.2_ref91) 2010; 62 Donath (10.5213/inj.2012.16.1.2_ref77) 2011; 11 Akira (10.5213/inj.2012.16.1.2_ref2) 2011; 366 Poeck (10.5213/inj.2012.16.1.2_ref47) 2010; 11 Hoffman (10.5213/inj.2012.16.1.2_ref54) 2001; 29 Abela (10.5213/inj.2012.16.1.2_ref65) 2010; 4 McGonagle (10.5213/inj.2012.16.1.2_ref60) 2007; 66 Nour (10.5213/inj.2012.16.1.2_ref51) 2011; 286 Menu (10.5213/inj.2012.16.1.2_ref84) 2012; 3 Rajan (10.5213/inj.2012.16.1.2_ref46) 2011; 85 He (10.5213/inj.2012.16.1.2_ref67) 2010; 184 Kahn (10.5213/inj.2012.16.1.2_ref70) 2006; 444 Agostini (10.5213/inj.2012.16.1.2_ref6) 2004; 20 Dalbeth (10.5213/inj.2012.16.1.2_ref89) 2011; 7 Burdette (10.5213/inj.2012.16.1.2_ref49) 2012; 93 Torres (10.5213/inj.2012.16.1.2_ref59) 2009; 68 Gasse (10.5213/inj.2012.16.1.2_ref62) 2009; 179 Zhou (10.5213/inj.2012.16.1.2_ref81) 2010; 11 Dowds (10.5213/inj.2012.16.1.2_ref56) 2004; 279 So (10.5213/inj.2012.16.1.2_ref61) 2007; 9 Feldmann (10.5213/inj.2012.16.1.2_ref55) 2002; 71 Maedler (10.5213/inj.2012.16.1.2_ref75) 2009; 9 Mitroulis (10.5213/inj.2012.16.1.2_ref94) 2010; 21 Komura (10.5213/inj.2012.16.1.2_ref83) 2010; 59 Hvid (10.5213/inj.2012.16.1.2_ref36) 2007; 9 Mariathasan (10.5213/inj.2012.16.1.2_ref9) 2006; 440 Broz (10.5213/inj.2012.16.1.2_ref33) 2010; 207 Palm (10.5213/inj.2012.16.1.2_ref1) 2009; 227 Latz (10.5213/inj.2012.16.1.2_ref3) 2010; 22 Kanneganti (10.5213/inj.2012.16.1.2_ref8) 2006; 281 Craven (10.5213/inj.2012.16.1.2_ref29) 2009; 4 Carlsson (10.5213/inj.2012.16.1.2_ref45) 2010; 6 Hawkins (10.5213/inj.2012.16.1.2_ref86) 2003; 348 Atianand (10.5213/inj.2012.16.1.2_ref38) 2011; 286 Bendtzen (10.5213/inj.2012.16.1.2_ref73) 1986; 232 Pétrilli (10.5213/inj.2012.16.1.2_ref21) 2007; 14 Duewell (10.5213/inj.2012.16.1.2_ref68) 2010; 464 Cooper (10.5213/inj.2012.16.1.2_ref78) 1987; 84 Böni-Schnetzler (10.5213/inj.2012.16.1.2_ref74) 2009; 150 Ehses (10.5213/inj.2012.16.1.2_ref76) 2009; 106 Sutterwala (10.5213/inj.2012.16.1.2_ref11) 2006; 24 Westwell-Roper (10.5213/inj.2012.16.1.2_ref80) 2011; 187 Masters (10.5213/inj.2012.16.1.2_ref5) 2009; 27 Segovia (10.5213/inj.2012.16.1.2_ref48) 2012; 7 Delaloye (10.5213/inj.2012.16.1.2_ref52) 2009; 5 Ceballos-Olvera (10.5213/inj.2012.16.1.2_ref34) 2011; 7 Harder (10.5213/inj.2012.16.1.2_ref30) 2009; 183 Terkeltaub (10.5213/inj.2012.16.1.2_ref90) 2009; 68 Hornung (10.5213/inj.2012.16.1.2_ref20) 2008; 9 Strowig (10.5213/inj.2012.16.1.2_ref4) 2012; 481 Hise (10.5213/inj.2012.16.1.2_ref24) 2009; 5 Duncan (10.5213/inj.2012.16.1.2_ref35) 2009; 182 Martin (10.5213/inj.2012.16.1.2_ref58) 2009; 60 Gross (10.5213/inj.2012.16.1.2_ref15) 2009; 459 Spilberg (10.5213/inj.2012.16.1.2_ref57) 1975; 18 McGonagle (10.5213/inj.2012.16.1.2_ref92) 2008; 58 Saïd-Sadier (10.5213/inj.2012.16.1.2_ref27) 2010; 5 Hoffman (10.5213/inj.2012.16.1.2_ref87) 2004; 364 Stack (10.5213/inj.2012.16.1.2_ref93) 2005; 175 Wong (10.5213/inj.2012.16.1.2_ref43) 2011; 13 18604209 - Nat Immunol. 2008 Aug;9(8):857-65 22278288 - Cell Death Dis. 2012 Jan 26;3:e261 19915568 - Nat Immunol. 2010 Jan;11(1):63-9 21385879 - J Biol Chem. 2011 May 20;286(20):17921-33 15030775 - Immunity. 2004 Mar;20(3):319-25 21196255 - Front Biosci (Landmark Ed). 2011 Jan 01;16:1663-74 19684085 - J Immunol. 2009 Sep 15;183(6):3578-81 21876553 - Immunol Cell Biol. 2012 Jul;90(6):601-10 21122648 - J Clin Lipidol. 2010 May-Jun;4(3):156-64 20041168 - PLoS Pathog. 2009 Dec;5(12):e1000510 22258606 - Nature. 2012 Jan 18;481(7381):278-86 17998217 - Ann Rheum Dis. 2007 Dec;66(12):1683-4 19812205 - J Immunol. 2009 Nov 1;183(9):5823-9 16407890 - Nature. 2006 Mar 9;440(7081):228-32 19218193 - Am J Respir Crit Care Med. 2009 May 15;179(10 ):903-13 19543380 - PLoS Pathog. 2009 Jun;5(6):e1000480 236759 - Arthritis Rheum. 1975 Mar-Apr;18(2):129-34 21289611 - Nat Rev Rheumatol. 2011 Feb;7(2):77-8 17599094 - Cell Death Differ. 2007 Sep;14 (9):1583-9 20351693 - Nat Immunol. 2010 May;11(5):385-93 19302049 - Annu Rev Immunol. 2009;27:621-68 21893536 - Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2748-55 3317417 - Proc Natl Acad Sci U S A. 1987 Dec;84(23):8628-32 12606524 - Diabetes. 2003 Mar;52(3):812-7 12792854 - J Infect Dis. 2003 Jun 15;187 Suppl 2:S370-84 17614966 - Cell Microbiol. 2007 Dec;9(12):2795-803 19414800 - J Immunol. 2009 May 15;182(10 ):6460-9 21289120 - J Virol. 2011 May;85(9):4167-72 19635719 - Ann Rheum Dis. 2009 Oct;68(10):1613-7 18604214 - Nat Immunol. 2008 Aug;9(8):847-56 19666548 - Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13998-4003 18668535 - Arthritis Rheum. 2008 Aug;58(8):2443-52 9887164 - N Engl J Med. 1999 Jan 14;340(2):115-26 20393140 - J Immunol. 2010 May 15;184(10 ):5743-54 21740493 - Cell Microbiol. 2011 Sep;13(9):1371-84 19454352 - Cell Host Microbe. 2009 May 8;5(5):487-97 16081838 - J Immunol. 2005 Aug 15;175(4):2630-4 19819943 - Endocrinology. 2009 Dec;150(12):5218-29 19826485 - PLoS One. 2009 Oct 14;4(10 ):e7446 20368800 - PLoS One. 2010 Apr 02;5(4):e10008 19339971 - Nature. 2009 May 21;459(7245):433-6 21427505 - J Atheroscler Thromb. 2011;18(5):351-8 17167471 - Nature. 2006 Dec 14;444(7121):840-6 19158679 - Nat Immunol. 2009 Mar;10(3):266-72 16546100 - Immunity. 2006 Mar;24(3):317-27 20428172 - Nature. 2010 Apr 29;464(7293):1357-61 16407889 - Nature. 2006 Mar 9;440(7081):237-41 20502346 - J Acquir Immune Defic Syndr. 2010 Jul;54(3):236-40 20603313 - J Exp Med. 2010 Aug 2;207 (8):1745-55 20493414 - Eur J Intern Med. 2010 Jun;21(3):157-63 3086977 - Science. 1986 Jun 20;232(4757):1545-7 20463815 - PLoS Pathog. 2010 May 06;6(5):e1000895 19120487 - Immunol Rev. 2009 Jan;227(1):221-33 20533546 - Arthritis Rheum. 2010 Oct;62(10 ):3064-76 16648852 - Nat Immunol. 2006 Jun;7(6):576-82 15541451 - Lancet. 2004 Nov 13-19;364(9447):1779-85 12815153 - N Engl J Med. 2003 Jun 19;348(25):2583-4 22241982 - PLoS Pathog. 2011 Dec;7(12 ):e1002452 18240249 - Arthritis Rheum. 2008 Feb;58(2):631-3 20668705 - PLoS One. 2010 Jul 23;5(7):e11765 20808838 - PLoS One. 2010 Aug 20;5(8):e12320 19767732 - Nat Med. 2009 Oct;15(10 ):1170-8 22101787 - Eur J Immunol. 2012 Feb;42(2):374-84 11687797 - Nat Genet. 2001 Nov;29(3):301-5 20007575 - J Immunol. 2009 Dec 15;183(12 ):8061-7 20075245 - Science. 2010 Jan 15;327(5963):296-300 21930705 - J Biol Chem. 2011 Nov 11;286(45):39033-42 21733753 - Trends Immunol. 2011 Aug;32(8):373-9 15020601 - J Biol Chem. 2004 May 21;279(21):21924-8 17008311 - J Biol Chem. 2006 Dec 1;281(48):36560-8 10577983 - Ann Rheum Dis. 1999 Nov;58 Suppl 1:I96-8 21151103 - Nat Immunol. 2011 Mar;12 (3):222-30 19302047 - Annu Rev Immunol. 2009;27:519-50 20148899 - Cell Microbiol. 2010 Aug;12 (8):1046-63 20348425 - J Immunol. 2010 May 1;184(9):5287-97 20835230 - Nat Immunol. 2010 Oct;11(10 ):897-904 16648853 - Nat Immunol. 2006 Jun;7(6):569-75 19875615 - Diabetes. 2010 Feb;59(2):440-7 19604125 - Expert Opin Biol Ther. 2009 Sep;9(9):1177-88 20023662 - Nat Immunol. 2010 Feb;11(2):136-40 20060699 - Curr Opin Immunol. 2010 Feb;22(1):28-33 21813778 - J Immunol. 2011 Sep 1;187(5):2755-65 21124315 - Nature. 2011 Jan 13;469(7329):221-5 21994322 - J Gen Virol. 2012 Feb;93(Pt 2):235-46 16186395 - Diabetes. 2005 Oct;54(10):2932-8 19528034 - Ann Rheum Dis. 2009 Oct;68(10):1602-8 12032915 - Am J Hum Genet. 2002 Jul;71(1):198-203 18407066 - Cell Host Microbe. 2008 Apr 17;3(4):224-32 19116939 - Arthritis Rheum. 2009 Jan;60(1):281-9 17352828 - Arthritis Res Ther. 2007;9(2):R28 19959758 - Diabetes. 2010 Mar;59(3):634-43 20421639 - J Immunol. 2010 Jun 1;184(11):6335-42 21233852 - Nat Rev Immunol. 2011 Feb;11(2):98-107 22295065 - PLoS One. 2012;7(1):e29695 |
References_xml | – volume: 5 start-page: e11765 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref69 publication-title: PLoS One doi: 10.1371/journal.pone.0011765 – volume: 18 start-page: 129 year: 1975 ident: 10.5213/inj.2012.16.1.2_ref57 publication-title: Arthritis Rheum doi: 10.1002/art.1780180208 – volume: 440 start-page: 228 year: 2006 ident: 10.5213/inj.2012.16.1.2_ref9 publication-title: Nature doi: 10.1038/nature04515 – volume: 187 start-page: S370 issue: Suppl 2 year: 2003 ident: 10.5213/inj.2012.16.1.2_ref22 publication-title: J Infect Dis doi: 10.1086/374751 – volume: 14 start-page: 1583 year: 2007 ident: 10.5213/inj.2012.16.1.2_ref21 publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4402195 – volume: 7 start-page: e29695 year: 2012 ident: 10.5213/inj.2012.16.1.2_ref48 publication-title: PLoS One doi: 10.1371/journal.pone.0029695 – volume: 184 start-page: 5743 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref67 publication-title: J Immunol doi: 10.4049/jimmunol.0903937 – volume: 444 start-page: 840 year: 2006 ident: 10.5213/inj.2012.16.1.2_ref70 publication-title: Nature doi: 10.1038/nature05482 – volume: 22 start-page: 28 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref3 publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2009.12.004 – volume: 179 start-page: 903 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref62 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200808-1274OC – volume: 58 start-page: 2443 year: 2008 ident: 10.5213/inj.2012.16.1.2_ref88 publication-title: Arthritis Rheum doi: 10.1002/art.23687 – volume: 59 start-page: 634 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref83 publication-title: Diabetes doi: 10.2337/db09-0659 – volume: 13 start-page: 1371 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref43 publication-title: Cell Microbiol doi: 10.1111/j.1462-5822.2011.01625.x – volume: 68 start-page: 1602 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref59 publication-title: Ann Rheum Dis doi: 10.1136/ard.2009.109355 – volume: 11 start-page: 136 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref81 publication-title: Nat Immunol doi: 10.1038/ni.1831 – volume: 183 start-page: 8061 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref26 publication-title: J Immunol doi: 10.4049/jimmunol.0902477 – volume: 54 start-page: 2932 year: 2005 ident: 10.5213/inj.2012.16.1.2_ref72 publication-title: Diabetes doi: 10.2337/diabetes.54.10.2932 – volume: 85 start-page: 4167 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref46 publication-title: J Virol doi: 10.1128/JVI.01687-10 – volume: 327 start-page: 296 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref13 publication-title: Science doi: 10.1126/science.1184003 – volume: 286 start-page: 39033 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref38 publication-title: J Biol Chem doi: 10.1074/jbc.M111.244079 – volume: 93 start-page: 235 issue: Pt 2 year: 2012 ident: 10.5213/inj.2012.16.1.2_ref49 publication-title: J Gen Virol doi: 10.1099/vir.0.034033-0 – volume: 182 start-page: 6460 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref35 publication-title: J Immunol doi: 10.4049/jimmunol.0802696 – volume: 11 start-page: 385 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref37 publication-title: Nat Immunol doi: 10.1038/ni.1859 – volume: 3 start-page: e261 year: 2012 ident: 10.5213/inj.2012.16.1.2_ref84 publication-title: Cell Death Dis doi: 10.1038/cddis.2011.132 – volume: 281 start-page: 36560 year: 2006 ident: 10.5213/inj.2012.16.1.2_ref8 publication-title: J Biol Chem doi: 10.1074/jbc.M607594200 – volume: 54 start-page: 236 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref53 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e3181dd17d4 – volume: 9 start-page: R28 year: 2007 ident: 10.5213/inj.2012.16.1.2_ref61 publication-title: Arthritis Res Ther doi: 10.1186/ar2143 – volume: 59 start-page: 440 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref82 publication-title: Diabetes doi: 10.2337/db09-0949 – volume: 12 start-page: 1046 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref40 publication-title: Cell Microbiol doi: 10.1111/j.1462-5822.2010.01450.x – volume: 29 start-page: 301 year: 2001 ident: 10.5213/inj.2012.16.1.2_ref54 publication-title: Nat Genet doi: 10.1038/ng756 – volume: 183 start-page: 3578 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref25 publication-title: J Immunol doi: 10.4049/jimmunol.0901323 – volume: 16 start-page: 1663 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref66 publication-title: Front Biosci doi: 10.2741/3812 – volume: 7 start-page: e1002452 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref34 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002452 – volume: 5 start-page: e10008 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref27 publication-title: PLoS One doi: 10.1371/journal.pone.0010008 – volume: 232 start-page: 1545 year: 1986 ident: 10.5213/inj.2012.16.1.2_ref73 publication-title: Science doi: 10.1126/science.3086977 – volume: 24 start-page: 317 year: 2006 ident: 10.5213/inj.2012.16.1.2_ref11 publication-title: Immunity doi: 10.1016/j.immuni.2006.02.004 – volume: 9 start-page: 857 year: 2008 ident: 10.5213/inj.2012.16.1.2_ref19 publication-title: Nat Immunol doi: 10.1038/ni.1636 – volume: 7 start-page: 576 year: 2006 ident: 10.5213/inj.2012.16.1.2_ref14 publication-title: Nat Immunol doi: 10.1038/ni1346 – volume: 52 start-page: 812 year: 2003 ident: 10.5213/inj.2012.16.1.2_ref71 publication-title: Diabetes doi: 10.2337/diabetes.52.3.812 – volume: 9 start-page: 2795 year: 2007 ident: 10.5213/inj.2012.16.1.2_ref36 publication-title: Cell Microbiol doi: 10.1111/j.1462-5822.2007.00996.x – volume: 464 start-page: 1357 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref68 publication-title: Nature doi: 10.1038/nature08938 – volume: 21 start-page: 157 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref94 publication-title: Eur J Intern Med doi: 10.1016/j.ejim.2010.03.005 – volume: 27 start-page: 621 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref5 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.25.022106.141627 – volume: 175 start-page: 2630 year: 2005 ident: 10.5213/inj.2012.16.1.2_ref93 publication-title: J Immunol doi: 10.4049/jimmunol.175.4.2630 – volume: 18 start-page: 351 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref64 publication-title: J Atheroscler Thromb doi: 10.5551/jat.7591 – volume: 62 start-page: 3064 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref91 publication-title: Arthritis Rheum doi: 10.1002/art.27600 – volume: 66 start-page: 1683 year: 2007 ident: 10.5213/inj.2012.16.1.2_ref60 publication-title: Ann Rheum Dis doi: 10.1136/ard.2007.073759 – volume: 364 start-page: 1779 year: 2004 ident: 10.5213/inj.2012.16.1.2_ref87 publication-title: Lancet doi: 10.1016/S0140-6736(04)17401-1 – volume: 481 start-page: 278 year: 2012 ident: 10.5213/inj.2012.16.1.2_ref4 publication-title: Nature doi: 10.1038/nature10759 – volume: 7 start-page: 569 year: 2006 ident: 10.5213/inj.2012.16.1.2_ref32 publication-title: Nat Immunol doi: 10.1038/ni1344 – volume: 5 start-page: e12320 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref41 publication-title: PLoS One doi: 10.1371/journal.pone.0012320 – volume: 150 start-page: 5218 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref74 publication-title: Endocrinology doi: 10.1210/en.2009-0543 – volume: 459 start-page: 433 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref15 publication-title: Nature doi: 10.1038/nature07965 – volume: 440 start-page: 237 year: 2006 ident: 10.5213/inj.2012.16.1.2_ref10 publication-title: Nature doi: 10.1038/nature04516 – volume: 340 start-page: 115 year: 1999 ident: 10.5213/inj.2012.16.1.2_ref63 publication-title: N Engl J Med doi: 10.1056/NEJM199901143400207 – volume: 9 start-page: 1177 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref75 publication-title: Expert Opin Biol Ther doi: 10.1517/14712590903136688 – volume: 469 start-page: 221 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref17 publication-title: Nature doi: 10.1038/nature09663 – volume: 184 start-page: 6335 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref28 publication-title: J Immunol doi: 10.4049/jimmunol.0903019 – year: 2011 ident: 10.5213/inj.2012.16.1.2_ref44 publication-title: Immunol Cell Biol – volume: 10 start-page: 266 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref50 publication-title: Nat Immunol doi: 10.1038/ni.1702 – volume: 71 start-page: 198 year: 2002 ident: 10.5213/inj.2012.16.1.2_ref55 publication-title: Am J Hum Genet doi: 10.1086/341357 – volume: 84 start-page: 8628 year: 1987 ident: 10.5213/inj.2012.16.1.2_ref78 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.84.23.8628 – volume: 42 start-page: 374 year: 2012 ident: 10.5213/inj.2012.16.1.2_ref42 publication-title: Eur J Immunol doi: 10.1002/eji.201141548 – volume: 4 start-page: e7446 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref29 publication-title: PLoS One doi: 10.1371/journal.pone.0007446 – volume: 286 start-page: 17921 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref51 publication-title: J Biol Chem doi: 10.1074/jbc.M110.210575 – volume: 184 start-page: 5287 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref31 publication-title: J Immunol doi: 10.4049/jimmunol.0903536 – volume: 5 start-page: e1000480 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref52 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1000480 – volume: 15 start-page: 1170 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref16 publication-title: Nat Med doi: 10.1038/nm.2028 – volume: 279 start-page: 21924 year: 2004 ident: 10.5213/inj.2012.16.1.2_ref56 publication-title: J Biol Chem doi: 10.1074/jbc.M401178200 – volume: 4 start-page: 156 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref65 publication-title: J Clin Lipidol doi: 10.1016/j.jacl.2010.03.003 – volume: 20 start-page: 319 year: 2004 ident: 10.5213/inj.2012.16.1.2_ref6 publication-title: Immunity doi: 10.1016/S1074-7613(04)00046-9 – volume: 27 start-page: 519 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref23 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.021908.132612 – volume: 227 start-page: 221 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref1 publication-title: Immunol Rev doi: 10.1111/j.1600-065X.2008.00731.x – volume: 5 start-page: e1000510 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref7 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1000510 – volume: 6 start-page: e1000895 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref45 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1000895 – volume: 366 start-page: 2748 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref2 publication-title: Philos Trans R Soc Lond B Biol Sci doi: 10.1098/rstb.2011.0106 – volume: 5 start-page: 487 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref24 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2009.05.002 – volume: 207 start-page: 1745 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref33 publication-title: J Exp Med doi: 10.1084/jem.20100257 – volume: 11 start-page: 63 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref47 publication-title: Nat Immunol doi: 10.1038/ni.1824 – volume: 32 start-page: 373 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref12 publication-title: Trends Immunol doi: 10.1016/j.it.2011.05.004 – volume: 348 start-page: 2583 year: 2003 ident: 10.5213/inj.2012.16.1.2_ref86 publication-title: N Engl J Med doi: 10.1056/NEJM200306193482523 – volume: 7 start-page: 77 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref89 publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2010.222 – volume: 106 start-page: 13998 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref76 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0810087106 – volume: 183 start-page: 5823 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref30 publication-title: J Immunol doi: 10.4049/jimmunol.0900444 – volume: 11 start-page: 98 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref77 publication-title: Nat Rev Immunol doi: 10.1038/nri2925 – volume: 187 start-page: 2755 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref80 publication-title: J Immunol doi: 10.4049/jimmunol.1002854 – volume: 58 start-page: 631 year: 2008 ident: 10.5213/inj.2012.16.1.2_ref92 publication-title: Arthritis Rheum doi: 10.1002/art.23119 – volume: 12 start-page: 222 year: 2011 ident: 10.5213/inj.2012.16.1.2_ref18 publication-title: Nat Immunol doi: 10.1038/ni.1980 – volume: 9 start-page: 847 year: 2008 ident: 10.5213/inj.2012.16.1.2_ref20 publication-title: Nat Immunol doi: 10.1038/ni.1631 – volume: 11 start-page: 897 year: 2010 ident: 10.5213/inj.2012.16.1.2_ref79 publication-title: Nat Immunol doi: 10.1038/ni.1935 – volume: 60 start-page: 281 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref58 publication-title: Arthritis Rheum doi: 10.1002/art.24185 – volume: 58 start-page: I96 issue: Suppl 1 year: 1999 ident: 10.5213/inj.2012.16.1.2_ref85 publication-title: Ann Rheum Dis doi: 10.1136/ard.58.2008.i96 – volume: 68 start-page: 1613 year: 2009 ident: 10.5213/inj.2012.16.1.2_ref90 publication-title: Ann Rheum Dis doi: 10.1136/ard.2009.108936 – volume: 3 start-page: 224 year: 2008 ident: 10.5213/inj.2012.16.1.2_ref39 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2008.03.003 – reference: 20023662 - Nat Immunol. 2010 Feb;11(2):136-40 – reference: 20603313 - J Exp Med. 2010 Aug 2;207 (8):1745-55 – reference: 19666548 - Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13998-4003 – reference: 15020601 - J Biol Chem. 2004 May 21;279(21):21924-8 – reference: 21930705 - J Biol Chem. 2011 Nov 11;286(45):39033-42 – reference: 19116939 - Arthritis Rheum. 2009 Jan;60(1):281-9 – reference: 18407066 - Cell Host Microbe. 2008 Apr 17;3(4):224-32 – reference: 19819943 - Endocrinology. 2009 Dec;150(12):5218-29 – reference: 21124315 - Nature. 2011 Jan 13;469(7329):221-5 – reference: 19158679 - Nat Immunol. 2009 Mar;10(3):266-72 – reference: 21151103 - Nat Immunol. 2011 Mar;12 (3):222-30 – reference: 18604214 - Nat Immunol. 2008 Aug;9(8):847-56 – reference: 3086977 - Science. 1986 Jun 20;232(4757):1545-7 – reference: 18668535 - Arthritis Rheum. 2008 Aug;58(8):2443-52 – reference: 12032915 - Am J Hum Genet. 2002 Jul;71(1):198-203 – reference: 19414800 - J Immunol. 2009 May 15;182(10 ):6460-9 – reference: 19684085 - J Immunol. 2009 Sep 15;183(6):3578-81 – reference: 10577983 - Ann Rheum Dis. 1999 Nov;58 Suppl 1:I96-8 – reference: 20348425 - J Immunol. 2010 May 1;184(9):5287-97 – reference: 19604125 - Expert Opin Biol Ther. 2009 Sep;9(9):1177-88 – reference: 21876553 - Immunol Cell Biol. 2012 Jul;90(6):601-10 – reference: 19875615 - Diabetes. 2010 Feb;59(2):440-7 – reference: 3317417 - Proc Natl Acad Sci U S A. 1987 Dec;84(23):8628-32 – reference: 16546100 - Immunity. 2006 Mar;24(3):317-27 – reference: 19120487 - Immunol Rev. 2009 Jan;227(1):221-33 – reference: 18604209 - Nat Immunol. 2008 Aug;9(8):857-65 – reference: 12815153 - N Engl J Med. 2003 Jun 19;348(25):2583-4 – reference: 20668705 - PLoS One. 2010 Jul 23;5(7):e11765 – reference: 15541451 - Lancet. 2004 Nov 13-19;364(9447):1779-85 – reference: 20368800 - PLoS One. 2010 Apr 02;5(4):e10008 – reference: 20393140 - J Immunol. 2010 May 15;184(10 ):5743-54 – reference: 19302047 - Annu Rev Immunol. 2009;27:519-50 – reference: 20075245 - Science. 2010 Jan 15;327(5963):296-300 – reference: 21385879 - J Biol Chem. 2011 May 20;286(20):17921-33 – reference: 16648853 - Nat Immunol. 2006 Jun;7(6):569-75 – reference: 20493414 - Eur J Intern Med. 2010 Jun;21(3):157-63 – reference: 22241982 - PLoS Pathog. 2011 Dec;7(12 ):e1002452 – reference: 21122648 - J Clin Lipidol. 2010 May-Jun;4(3):156-64 – reference: 20148899 - Cell Microbiol. 2010 Aug;12 (8):1046-63 – reference: 17998217 - Ann Rheum Dis. 2007 Dec;66(12):1683-4 – reference: 21196255 - Front Biosci (Landmark Ed). 2011 Jan 01;16:1663-74 – reference: 9887164 - N Engl J Med. 1999 Jan 14;340(2):115-26 – reference: 21813778 - J Immunol. 2011 Sep 1;187(5):2755-65 – reference: 19528034 - Ann Rheum Dis. 2009 Oct;68(10):1602-8 – reference: 20060699 - Curr Opin Immunol. 2010 Feb;22(1):28-33 – reference: 19454352 - Cell Host Microbe. 2009 May 8;5(5):487-97 – reference: 16407889 - Nature. 2006 Mar 9;440(7081):237-41 – reference: 21427505 - J Atheroscler Thromb. 2011;18(5):351-8 – reference: 17352828 - Arthritis Res Ther. 2007;9(2):R28 – reference: 19339971 - Nature. 2009 May 21;459(7245):433-6 – reference: 22101787 - Eur J Immunol. 2012 Feb;42(2):374-84 – reference: 22295065 - PLoS One. 2012;7(1):e29695 – reference: 16407890 - Nature. 2006 Mar 9;440(7081):228-32 – reference: 20007575 - J Immunol. 2009 Dec 15;183(12 ):8061-7 – reference: 20835230 - Nat Immunol. 2010 Oct;11(10 ):897-904 – reference: 22258606 - Nature. 2012 Jan 18;481(7381):278-86 – reference: 20351693 - Nat Immunol. 2010 May;11(5):385-93 – reference: 21740493 - Cell Microbiol. 2011 Sep;13(9):1371-84 – reference: 17167471 - Nature. 2006 Dec 14;444(7121):840-6 – reference: 16186395 - Diabetes. 2005 Oct;54(10):2932-8 – reference: 20041168 - PLoS Pathog. 2009 Dec;5(12):e1000510 – reference: 12606524 - Diabetes. 2003 Mar;52(3):812-7 – reference: 11687797 - Nat Genet. 2001 Nov;29(3):301-5 – reference: 19543380 - PLoS Pathog. 2009 Jun;5(6):e1000480 – reference: 17599094 - Cell Death Differ. 2007 Sep;14 (9):1583-9 – reference: 21233852 - Nat Rev Immunol. 2011 Feb;11(2):98-107 – reference: 17614966 - Cell Microbiol. 2007 Dec;9(12):2795-803 – reference: 20421639 - J Immunol. 2010 Jun 1;184(11):6335-42 – reference: 19767732 - Nat Med. 2009 Oct;15(10 ):1170-8 – reference: 19218193 - Am J Respir Crit Care Med. 2009 May 15;179(10 ):903-13 – reference: 19302049 - Annu Rev Immunol. 2009;27:621-68 – reference: 17008311 - J Biol Chem. 2006 Dec 1;281(48):36560-8 – reference: 20533546 - Arthritis Rheum. 2010 Oct;62(10 ):3064-76 – reference: 20808838 - PLoS One. 2010 Aug 20;5(8):e12320 – reference: 15030775 - Immunity. 2004 Mar;20(3):319-25 – reference: 16081838 - J Immunol. 2005 Aug 15;175(4):2630-4 – reference: 236759 - Arthritis Rheum. 1975 Mar-Apr;18(2):129-34 – reference: 21289611 - Nat Rev Rheumatol. 2011 Feb;7(2):77-8 – reference: 21733753 - Trends Immunol. 2011 Aug;32(8):373-9 – reference: 16648852 - Nat Immunol. 2006 Jun;7(6):576-82 – reference: 19826485 - PLoS One. 2009 Oct 14;4(10 ):e7446 – reference: 19959758 - Diabetes. 2010 Mar;59(3):634-43 – reference: 19915568 - Nat Immunol. 2010 Jan;11(1):63-9 – reference: 21289120 - J Virol. 2011 May;85(9):4167-72 – reference: 20502346 - J Acquir Immune Defic Syndr. 2010 Jul;54(3):236-40 – reference: 18240249 - Arthritis Rheum. 2008 Feb;58(2):631-3 – reference: 19635719 - Ann Rheum Dis. 2009 Oct;68(10):1613-7 – reference: 20428172 - Nature. 2010 Apr 29;464(7293):1357-61 – reference: 19812205 - J Immunol. 2009 Nov 1;183(9):5823-9 – reference: 12792854 - J Infect Dis. 2003 Jun 15;187 Suppl 2:S370-84 – reference: 21994322 - J Gen Virol. 2012 Feb;93(Pt 2):235-46 – reference: 22278288 - Cell Death Dis. 2012 Jan 26;3:e261 – reference: 20463815 - PLoS Pathog. 2010 May 06;6(5):e1000895 – reference: 21893536 - Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2748-55 |
SSID | ssj0000447057 |
Score | 2.128174 |
SecondaryResourceType | review_article |
Snippet | Among a number of innate receptors, the nucleotide-binding domain leucine-rich repeat containing (NLR) nucleotide oligomerization domain (NOD)-like receptor... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2 |
SubjectTerms | Defense mechanisms Inflammasomes Inflammation Review 비뇨기과학 |
Title | The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22500248 https://www.proquest.com/docview/1000403071 https://pubmed.ncbi.nlm.nih.gov/PMC3321399 https://doaj.org/article/6d8b1deae5134846b347a3b56394ba7f https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001647947 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | International Neurourology Journal, 2012, 16(1), 34, pp.2-12 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaqHlAvCGiBFKhMxYGLt0lsx8kRWqpt1VaoKtLeLNsZ0-3DQbvb_8_YSVe7iIoLp0h-SPZ4PDNfPP5MyCduuLOlcszkRjDhhGW1aBUTPMeaSHEH8X_H-UU1_iFOJ3Ky8tRXzAnr6YF7wR1UbW2LFgzIggt0lpYLZbiV6FmFNcpH65s3-QqYSjZYCJUnmk-s5EwopXpeH_RW_GAabmJSVzkqqhFixDWXlJj70dGEmf9b0Pln7uSKMzp-QZ4PUST90o_-JdmA8Io8Ox_OybfJBFefXnZ3QDtPL84uWbqyAi39HmkZpoFyehI8KsO9mXf3QLFk3M0X9Ag8wlqgJrTLBvEUnh715zjzHXJ1_O3qcMyGNxSYQ6ywYCUY2ZaQ7ts2hXQgwauyNQjDQHhXWSFcUwOAzRuDUNlVrgIMuWpeOdnk_DXZDF2At4Q6r7y1JeS1l8KrAoUvMHZSsqzrGHplZPQoRe0GfvH4zMWdRpwRxa5R7DqKXReVLnSZkc_LDr96ao2nm36Ny7JsFjmxUwFqih40Rf9LUzKyj4uqb9009Y_fn52-nWlEDicp1Q0Be0Y-Pq65xo0WT09MgO5hHsmd0eChScSZvul1YDkeNIqJHC4jak071ga8XhOm14nMm3Ocb9Ps_o8ZviNbUWh9itx7srmYPcAHjJkWdi9tj98jIRDl |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Role+of+NLR-related+Protein+3+Inflammasome+in+Host+Defense+and+Inflammatory+Diseases&rft.jtitle=International+neurourology+journal&rft.au=Chul-Su+Yang&rft.au=Dong-Min+Shin&rft.au=Eun-Kyeong+Jo&rft.date=2012-03-01&rft.pub=Korean+Continence+Society&rft.issn=2093-4777&rft.eissn=2093-6931&rft.volume=16&rft.issue=1&rft.spage=2&rft.epage=12&rft_id=info:doi/10.5213%2Finj.2012.16.1.2&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_6d8b1deae5134846b347a3b56394ba7f |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-4777&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-4777&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-4777&client=summon |